Stay updated on Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page.

Latest updates to the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page has updated its date references and removed the mention of FHCC South Lake Union, while adding the Fred Hutchinson Cancer Center as a key entity.SummaryDifference0.3%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page has updated the list of hospitals involved in a study and adjusted the number of locations from 202 to 201. Additionally, several future dates have been added, while some past dates have been removed.SummaryDifference1%
- Check31 days agoNo Change Detected
- Check38 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.6%
- Check45 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.0%
- Check60 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.0%
- Check67 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
Stay in the know with updates to Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page.